Teva at AAPS 2026 PharmSci 360

Oct 25–28, 2026 New Orleans, LA ~4k attendees Website

Teva brings 3 presentations to AAPS 2026 PharmSci 360 in New Orleans. Its program centres on the quality of phospholipid excipients and the public standards behind them. Its work also compares total and free drug assays for measuring a monoclonal antibody in monkey serum.

OrganizationAAPS 2026 PharmSci 360 Attendance
Teva
Tel Aviv, Israel
tevapharm.com
Large pharma
Global pharmaceutical company and one of the largest makers of generic medicines, also selling specialty and biosimilar drugs.
Poster
Mon Oct 26
1:30pm–2:30pm
Comparison of Total and Free Pharmacokinetic Assays for Quantifing MAb1, a Monoclonal Antibody Drug, in Monkey Serum
Solution Center · Poster M1330-06-33
Bioanalytics - Biomolecular
Talk
Mon Oct 26
2:10pm–3:10pm
Part of Excipient Quality in Complex Generics
Focus on Quality of Phospholipid Excipients: USP Standards, Materials Program, and Stakeholder Engagement
USP Spotlight Stage, Exhibit Hall
Excipient Quality in Complex Generics · with USP
Talk
Mon Oct 26
3:10pm–3:30pm
Part of Excipient Quality in Complex Generics
Panel Discussion and Q&A
USP Spotlight Stage, Exhibit Hall
Excipient Quality in Complex Generics · with Ascendia Pharmaceutical Solutions, USP, Pfizer

Explore the full AAPS 2026 PharmSci 360 dataset

Get in-depth attendee and institution profiles and research, to plan your meetings in New Orleans. Leave your work email and we’ll be in touch.

Privacy

Download the full AAPS 2026 PharmSci 360 CSV

Leave your work email and we’ll be in touch. The CSV adds attendee names, roles and contact details to the company and session data shown here.

Privacy

Instantly find 20 buyers from Teva

Get a list of who you should contact, their contact info, and what to say.

Totally free and instant, no sign up necessary!

Not affiliated with or endorsed by the American Association of Pharmaceutical Scientists (AAPS). Submit a correction